|
EQS-News: Douglas AG / Key word(s): Conference/Half Year Results Conference call on the results for the 2nd quarter 2023/24 (ending 31 March 2024) on 29 May 2024 23.05.2024 / 15:09 CET/CEST The issuer is solely responsible for the content of this announcement. Conference Call Invitation Conference call on the results for the 2nd quarter 2023/24 (ending 31 March 2024) on 29 May 2024 Düsseldorf, 23 May, 2024 – The DOUGLAS Group, Europe’s number one omnichannel destination for premium beauty, invites you to an analyst and investor update call on the second quarter 2023/24 on 29 March 2024. The conference call on the results will be held at 11:00 a.m. CEST on 29 May 2024. To participate in the conference call, please make use of one of the following options:
About the DOUGLAS Group The DOUGLAS Group, with its commercial brands DOUGLAS, NOCIBÉ, Parfumdreams and Niche Beauty, is the number one omnichannel premium beauty destination in Europe. The DOUGLAS Group is inspiring customers to live their own kind of beauty by offering a unique assortment online and in around 1,850 stores. With unparalleled size and access to customers, the DOUGLAS Group is the partner of choice for brands and offers a premium range of selective and exclusive brands as well as own corporate brands. The assortment includes fragrances, color cosmetics, skin care, hair care, accessories as well as beauty services. Strengthening its successful omnichannel positioning while consistently developing superior customer experience is at the heart of the DOUGLAS Group strategy “Let it Bloom – DOUGLAS 2026”. The winning business model is underpinned by the Group’s omnichannel proposition, leading brands, and data capabilities. In the financial year 2022/23, the DOUGLAS Group generated sales (net) of 4.1 billion euros and employed around 18,000 people across Europe. The DOUGLAS Group (Douglas AG) is listed at the Frankfurt Stock Exchange. For further information please visit the DOUGLAS Group Website. Investor Contact Stefanie Steiner 23.05.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News – a service of EQS Group AG. The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Pharmalittle: We’re reading about a canceled Roche trial, low VC biotech funding, and more
Top of the morning to you. Another steamy day is unfolding here at the Pharmalot campus, where the official mascots are scampering about and enjoying
August 6, 2024